SEARCH

SEARCH BY CITATION

References

  • Adegbola RA, Falade AG, Sam BE et al. (1994) The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatric Infectious Diseases 13, 975 982.
  • Adegbola RA, Mulholland EK, Falade AG et al. (1996) Haemophilus influenzae type b disease in the western region of The Gambia: background surveillance for a vaccine efficacy trial. Annals of Tropical Paediatrics 16, 103 111.
  • Adegbola RA, Usen SO, Weber M et al. (1999) Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine. Lancet 354, 1091 1092.
  • Akpede GO, Akuhwa RT, Ogiji EO, Ambe JP (1999) Risk factors for an adverse outcome in bacterial meningitis in the tropics: a reappraisal with focus on the significance and risk of seizures. Annals of Tropical Paediatrics 19, 151 159.
  • Anonymous (1993) 1993 population and housing census of The Gambia. Government of The Gambia, Banjul.
  • Baird DR, Whittle HC, Greenwood BM (1976) Mortality from pneumococcal meningitis. Lancet ii, 1344 1346.
  • Baraff LJ, Lee SI, Schriger DL (1993) Outcomes of bacterial meningitis in children: a meta-analysis. Pediatric Infectious Diseases 12, 389 394.
  • Bijlmer HA, van Alphen L, Greenwood BM et al. (1990) The epidemiology of Haemophilus influenzae meningitis in children under five years of age in The Gambia, West Africa. Journal of Infectious Diseases 161, 1210 1215.
  • Bohr V, Rasmussen N, Hansen B et al. (1985) Pneumococcal meningitis: an evaluation of prognosis factors in 164 cases based on mortality and on a study of lasting sequelae. Journal of Infection 10, 143 157.
  • Brewster DR & Greenwood BM (1993) Seasonal variation of paediatric diseases in The Gambia, West Africa. Annals of Tropical Paediatrics 13, 133 146.
  • Fortnum HM (1992) Hearing impairment after bacterial meningitis: a review. Archive of Diseases in Childhood 67, 1128 1133.
  • Girgis NI, Farid Z, Mikhail IA et al. (1989) Dexamethasone treatment for bacterial meningitis in children and adults. Pediatric Infectious Diseases 8, 848 851.
  • Greenwood BM (1984) Selective primary health care: strategies for control of disease in the developing world. XIII. Acute bacterial meningitis. Review of Infectious Diseases 6, 374 389.
  • Greenwood BM, Hassan-King M, Cleland PG, Macfarlane JT, Yahaya HN (1986) Sequential bacteriological findings in the cerebrospinal fluid of Nigerian patients with pneumococcal meningitis. Journal of Infection 12, 49 56.
  • Grimwood K, Nolan TM, Bond L, Anderson VA, Catroppa C, Keir EH (1996) Risk factors for adverse outcomes of bacterial meningitis. Journal of Pediatrics & Child Health 32, 457 462.
  • Hailemeskel H & Tafari N (1978) Bacterial meningitis in childhood in an African city. Factors influencing etiology and outcome. Acta Pediatrica Scandinavica 67, 725 730.
  • Jaffar S, Leach A, Greenwood AM et al. (1997) Changes in the patterns of infant and childhood mortality in upper river division, The Gambia, from 1989 to 1993. Tropical Medicine and International Health 2, 28 37.
  • Kilpi T, Peltola H, Jauhiainen T, Kallio MJT (1995) Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. Pediatric Infectious Diseases 14, 270 278.
  • Lebel MH, Freij BJ, Syrogiannopoulos GA et al. (1988) Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. New England Journal of Medicine 319, 964 971.
  • Lindberg J, Rosenhall U, Nylen O, Ringner A (1977) Long-term outcome of Haemophilus influenzae meningitis related to antibiotic treatment. Pediatrics 60, 1 6.
  • Macaluso A, Pivetta S, Maggi RS, Tamburlini G, Cattaneo A (1996) Dexamethasone adjunctive therapy for bacterial meningitis in children: a retrospective study in Brazil. Annals of Tropical Paediatrics 16, 193 198.
  • Mbelle N, Wasas A, Huebner R et al. (1997) Immunogenicity and impact on carriage of 9-valent pneumococcal conjugate vaccine given to South African infants. Presented at the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto.
  • Mulholland K, Hilton S, Adegbola R et al. (1997) Randomised trial of Haemophilus influenzae type b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 349, 1191 1197.
  • O'dempsey TJ, McArdle TF, Morris J et al. (1996a) A study of risk factors for pneumococcal disease among children in a rural area of West Africa. International Journal of Epidemiology 25, 885 893.
  • O'dempsey TH, McArdle TF, Lloyd-Evans N et al. (1996b) Pneumococcal disease among children in a rural area of west Africa. Pediatric Infectious Diseases 15, 431 437.
  • Palmer A, Weber M, Bojang K, McKay T, Adegbola RA (1999) Acute bacterial meningitis in The Gambia. Journal of Tropical Pediatrics 45, 51 53.
  • Pomeroy SL, Holmes SJ, Dodge PR, Feigin RD (1990) Seizures and other neurologic sequelae of bacterial meningitis in children. New England Journal of Medicine 323, 1651 1656.
  • Sell SH (1987) Haemophilus influenzae type b meningitis: manifestations and long term sequelae. Pediatric Infectious Diseases 6, 775 778.
  • Sell SH (1983) Long term sequelae of bacterial meningitis in children. Pediatric Infectious Diseases 2, 90 93.
  • Shann F, Barker J, Poore P (1985) Chloramphenicol alone versus chloramphenicol plus penicillin for bacterial meningitis in children. Lancet 28, 681 684.
  • Whittle HC, Davidson NM, Greenwood BM et al. (1973) Trial of chloramphenicol for meningitis in northern savannah of Africa. British Medical Journal 18, 379 381.
  • World Health Organization (1998a) Child Health and Development 1996–97 Report. Document WHO/CHD/98.5. WHO, Geneva.
  • World Health Organization (1998b) Antimicrobial and support therapy for bacterial meningitis in children. Report of the meeting of 18–20 June 1997, Geneva, Switzerland. Document WHO/EMC/BAC/98.2 and WHO/CHD/98.6.WHO, Geneva.